RBC Capital has once again stamped an "Outperform" rating on The Cigna Group, signaling steady analyst confidence. The price ...

Guggenheim has reaffirmed its buy rating on The Cigna Group, setting a target price of $388, making investors grin. The Cigna ...

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Guggenheim analyst Jason Cassorla maintained a Buy rating on Cigna (CI – Research Report) today and set a price target of $388.00. The company’s shares closed yesterday at $31 ...

Hims & Hers Health, Inc. navigates strong growth and partnerships despite rising competitive risks. Click here to read an ...

Trevi Therapeutics (NASDAQ:TRVI – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Needham & Company LLC in a research note issued to investors on Tuesday ...

Wall Street’s worries about a ballooning deficit that threatens America’s status as a safe haven were reflected in a $16 billion Treasury sale that saw lackluster demand - with stocks, bonds and the ...

Currently, Cigna Group has a market capitalization of $88.11 billion. Buying $100 In CI: If an investor had bought $100 of CI stock 20 years ago, it would be worth $987.54 today based on a price ...

They currently have a $8.00 target price on the stock. A number of other research firms also recently issued reports on GANX. Chardan Capital reaffirmed a “buy” rating and set a $6.00 price ...

On May 15, Christopher Danely from Citi maintained a “Buy” rating on the stock with a price target of $110.00. A few days prior, J.P. Morgan analyst Harlan Sur maintained their bullish stance ...

Raymond James lifts CIGNA stock target to $385, keeps strong buy Open in App Get 45% Off Sign In Free Sign Up ...

Despite recent share price decline, I maintain a buy rating on Gartner due to resilient ... Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the ...